Clinical Trial Update: Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma [EARLY_Phase 1]

View source ↗

Summary

An exploratory Phase 1 study evaluated the histone deacetylase inhibitor AR-42 in vestibular schwannoma and meningioma; the trial was terminated and results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma
• Neurofibromatosis Type
• Vestibular Schwannoma

Drugs mentioned

• AR-42 (AR-42)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Vestibular Schwannoma, Meningioma | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2022-05-11